Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus.

被引：114

作者：

Benhamou, Y ^{[1
]}

Tubiana, R ^{[1
]}

Thibault, V ^{[1
]}

机构：

[1] Grp Hosp Pitie Salpetriere, F-75013 Paris, France

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2003年 / 348卷 / 02期

关键词：

D O I：

10.1056/NEJM200301093480218

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：177 / 178

页数：2

共 4 条

[1] Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study [J].

Benhamou, Y ;

Bochet, M ;

Thibault, V ;

Calvez, V ;

Fievet, MH ;

Vig, P ;

Gibbs, CS ;

Brosgart, C ;

Fry, J ;

Namini, H ;

Katiama, C ;

Poynard, T .

LANCET, 2001, 358 (9283) :718-723

[2] Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients [J].

Benhamou, Y ;

Bochet, M ;

Thibault, V ;

Di Martino, V ;

Caumes, E ;

Bricaire, F ;

Opolon, P ;

Katlama, C ;

Poynard, T .

HEPATOLOGY, 1999, 30 (05) :1302-1306

[3]

SQUIRES K, 2002, 9 C RETR OPP INF SEA

[4]

Ying C, 2000, J VIRAL HEPATITIS, V7, P161

← 1 →